Universe Pharmaceuticals INC Successfully Closed its Initial Public Offering

March 25, 2021

Ying Li

Guillaume de Sampigny

Universe Pharmaceuticals INC (the “Company”), a China-based pharmaceutical manufacturer and distributor, today announced the closing of its initial public offering (“Offering”) of 5,000,000 ordinary shares at a public offering price of US$5.00 per ordinary share. The Company received aggregate gross proceeds of US$25 million from this Offering, before deducting underwriting discounts and other related expenses.

The Company’s ordinary shares began trading on the Nasdaq Global Market on March 23, 2021 under the ticker symbol “UPC.”

Hunter Taubman Fischer & Li LLC acted as U.S. counsel to the Company. Hunter Taubman Fischer & Li LLC is a boutique law firm specializing in corporate, commercial and securities transactions, cross-border financing, immigration and taxation. Our team of lawyers works together so our clients can benefit from astute business experience and sophisticated legal solutions.